ImmunoCellular (IMUC:ASE) and Palatin Technologies (PTN:ASE) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at

I have used the analysis tools on the website to generate some of the content of this blog post. These tools and reports are available for free at

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on AMEX

Today’s data is for companies listed on the American Stock Exchange.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
PTN Palatin Technologies Inc 0.350000 152801806 None None 0.36 0.25
LEU Centrus Energy Corp 5.030000 9000000 None None 16.86 -0.90
MSN Emerson Radio Corp 1.380000 27065852 None 0.6858 1.54 0.97
ALN American Lorain Corp 0.500000 38274490 50.0000 0.0972 0.98 -0.62
NSPR InspireMD Inc 0.560000 7421846 2.1538 0.5388 1.15 1.15
IMUC ImmunoCellular Therapeutics Ltd 1.120000 3464175 None 8.1046 1.54 None

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

IMUC:ASE ImmunoCellular
ImmunoCellular has 9 employees and is headquartered in United States.
ImmunoCellular Therapeutics Ltd is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

PTN:ASE Palatin Technologies
Palatin Technologies has 22 employees and is headquartered in United States.
Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical need and commercial potential.

Free Valuation

Run a valuation on any of the companies listed above at or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.